RNA interference treatment targeting angiotensinogen lowers blood pressure

Carvalho, T

NATURE MEDICINE, 2023; 29 (12): 2962

Abstract

Nature Medicine explores the latest translation and clinical research news, with results from a phase 2 clinical trial of zilebesiran from Alnylam and......

Full Text Link